Rune Bjørneklett1,2, Sanjeevan Sriskandarajah3, Leif Bostad3,4. 1. Department of Clinical Medicine, University of Bergen, Bergen, Norway; and rune.bjoerneklett@helse-bergen.no. 2. Emergency Care Clinic and. 3. Department of Clinical Medicine, University of Bergen, Bergen, Norway; and. 4. Department of Pathology, Haukeland University Hospital, Bergen, Norway.
Abstract
BACKGROUND AND OBJECTIVES: A kidney biopsy is preferred for the diagnosis of ANCA-associated vasculitis with renal involvement. The aim of our study was to evaluate the prognostic value of a histopathologic classification scheme recently proposed by an international consortium of renal pathologists in a large Norwegian cohort. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Patients diagnosed with ANCA-associated GN were included from the Norwegian Kidney Biopsy Registry 1991-2012. Renal morphology was classified as focal, mixed, crescentic, or sclerotic. Study end point was ESRD. Patients were followed from kidney biopsy to end of 2012. RESULTS: Two hundred fifty patients with ≥10 glomeruli in the biopsy were included in our study. During a median follow-up of 3.5 years (0.7-7.6), 60 cases of ESRD occurred. Ninety-six (38%) biopsies were classified as focal, 61 (24%) biopsies were classified as mixed, 71 (28%) biopsies were classified as crescentic, and 22 (9%) biopsies were classified as sclerotic; 1- and 5-year cumulative renal survival rates were 96% and 90%, respectively, for the focal class, 86% and 75%, respectively, for the mixed class, 81% and 69%, respectively, for the crescentic class, and 56% and 51%, respectively, for the sclerotic class. By multivariate Cox regression analyses, the sclerotic class had a significantly worse renal prognosis than the focal (hazard ratio, 9.65; 95% confidence interval, 2.38 to 39.16) or combined mixed/crescentic classes (hazard ratio, 3.27; 95% confidence interval, 1.41 to 7.61), but no significant differences in outcome were observed in the crescentic class compared with the mixed class (hazard ratio, 1.13; 95% confidence interval, 0.44 to 2.87) or the combined mixed/crescentic class compared with the focal class (hazard ratio, 1.93; 95% confidence interval, 0.61 to 6.12). Accuracy by receiver operator characteristic curve analysis was estimated to be 0.72 (95% confidence interval, 0.65 to 0.80). In 108 additional patients with three to nine glomeruli in the biopsy, the prognostic value of this classification scheme was unchanged. CONCLUSIONS: The histopathologic classification is a predictor of renal outcome of moderate quality. Merging the mixed and crescentic classes in the future could simplify the scheme.
BACKGROUND AND OBJECTIVES: A kidney biopsy is preferred for the diagnosis of ANCA-associated vasculitis with renal involvement. The aim of our study was to evaluate the prognostic value of a histopathologic classification scheme recently proposed by an international consortium of renal pathologists in a large Norwegian cohort. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Patients diagnosed with ANCA-associated GN were included from the Norwegian Kidney Biopsy Registry 1991-2012. Renal morphology was classified as focal, mixed, crescentic, or sclerotic. Study end point was ESRD. Patients were followed from kidney biopsy to end of 2012. RESULTS: Two hundred fifty patients with ≥10 glomeruli in the biopsy were included in our study. During a median follow-up of 3.5 years (0.7-7.6), 60 cases of ESRD occurred. Ninety-six (38%) biopsies were classified as focal, 61 (24%) biopsies were classified as mixed, 71 (28%) biopsies were classified as crescentic, and 22 (9%) biopsies were classified as sclerotic; 1- and 5-year cumulative renal survival rates were 96% and 90%, respectively, for the focal class, 86% and 75%, respectively, for the mixed class, 81% and 69%, respectively, for the crescentic class, and 56% and 51%, respectively, for the sclerotic class. By multivariate Cox regression analyses, the sclerotic class had a significantly worse renal prognosis than the focal (hazard ratio, 9.65; 95% confidence interval, 2.38 to 39.16) or combined mixed/crescentic classes (hazard ratio, 3.27; 95% confidence interval, 1.41 to 7.61), but no significant differences in outcome were observed in the crescentic class compared with the mixed class (hazard ratio, 1.13; 95% confidence interval, 0.44 to 2.87) or the combined mixed/crescentic class compared with the focal class (hazard ratio, 1.93; 95% confidence interval, 0.61 to 6.12). Accuracy by receiver operator characteristic curve analysis was estimated to be 0.72 (95% confidence interval, 0.65 to 0.80). In 108 additional patients with three to nine glomeruli in the biopsy, the prognostic value of this classification scheme was unchanged. CONCLUSIONS: The histopathologic classification is a predictor of renal outcome of moderate quality. Merging the mixed and crescentic classes in the future could simplify the scheme.
Authors: Andrew S Levey; Josef Coresh; Tom Greene; Jane Marsh; Lesley A Stevens; John W Kusek; Frederick Van Lente Journal: Clin Chem Date: 2007-03-01 Impact factor: 8.327
Authors: I M Bajema; E C Hagen; B E Hansen; J Hermans; L H Noël; R Waldherr; F Ferrario; F J van der Woude; J A Bruijn Journal: Nephrol Dial Transplant Date: 1996-10 Impact factor: 5.992
Authors: Damien G Noone; Marinka Twilt; Wesley N Hayes; Paul S Thorner; Susanne Benseler; Ronald M Laxer; Rulan S Parekh; Diane Hebert Journal: Clin J Am Soc Nephrol Date: 2014-08-21 Impact factor: 8.237
Authors: Robert A F de Lind van Wijngaarden; Herbert A Hauer; Ron Wolterbeek; David R W Jayne; Gill Gaskin; Niels Rasmussen; Laure-Hélène Noël; Franco Ferrario; Rüdiger Waldherr; E Christiaan Hagen; Jan A Bruijn; Ingeborg M Bajema Journal: J Am Soc Nephrol Date: 2006-07-06 Impact factor: 10.121
Authors: Marc Hilhorst; Benjamin Wilde; Peter van Breda Vriesman; Pieter van Paassen; Jan Willem Cohen Tervaert Journal: J Am Soc Nephrol Date: 2013-06-13 Impact factor: 10.121
Authors: Sharon L Ford; Kevan R Polkinghorne; Anthony Longano; John Dowling; Sukhpal Dayan; Peter G Kerr; Stephen R Holdsworth; A Richard Kitching; Shaun A Summers Journal: Am J Kidney Dis Date: 2013-10-30 Impact factor: 8.860
Authors: H Marco; J Draibe; J Villacorta; L F Quintana; N Martin; R Garcia-Osuna; C Cabre; M A Martín-Gómez; A Balius; A Saurina; M Picazo; I Gich-Saladich; M Navarro-Díaz; M Praga; T Cavero; J Ballarin; M M Díaz-Encarnación Journal: Clin Rheumatol Date: 2018-03-09 Impact factor: 2.980
Authors: Alvise Berti; Emilie Cornec-Le Gall; Divi Cornec; Marta Casal Moura; Eric L Matteson; Cynthia S Crowson; Aishwarya Ravindran; Sanjeev Sethi; Fernando C Fervenza; Ulrich Specks Journal: Nephrol Dial Transplant Date: 2019-09-01 Impact factor: 5.992
Authors: Emma E van Daalen; Maria A C Wester Trejo; Arda Göçeroğlu; Franco Ferrario; Kensuke Joh; Laure-Hélène Noël; Yayoi Ogawa; Suzanne Wilhelmus; Miriam J Ball; Eva Honsova; Zdenka Hruskova; Renate Kain; Tomoyoshi Kimura; Marek Kollar; Andreas Kronbichler; Kristine Lindhard; Xavier Puéchal; Steven Salvatore; Wladimir Szpirt; Hideki Takizawa; Vladimir Tesar; Annelies E Berden; Olaf M Dekkers; E Christiaan Hagen; Jan Oosting; Chinar Rahmattulla; Ron Wolterbeek; Willem Jan Bos; Jan A Bruijn; Ingeborg M Bajema Journal: Clin J Am Soc Nephrol Date: 2020-07-28 Impact factor: 8.237
Authors: Jennifer Scott; Carolina Canepa; Antonia Buettner; Louise Ryan; Bróna Moloney; Sarah Cormican; Cathal Walsh; Arthur White; Alan D Salama; Mark A Little Journal: Sci Rep Date: 2021-06-22 Impact factor: 4.379